Cancer Type/Condition: Brain tumor, child: Other
Stage/Subtype: childhood pineoblastoma, untreated
Trial Type: Treatment
Trial Status: Active
1.
|
Phase: Phase III Type: Treatment Status: Active Age: 3 to 21 at diagnosis Sponsor: Other Protocol IDs: SJMB03, SJCRH-SJMB03, NCT00085202
|
|
2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: 05-122, MSKCC-05122, NCT00445965
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: Children Sponsor: Other Protocol IDs: 2005-12-009, NCT00798811
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 6 months to 17 years Sponsor: Other Protocol IDs: CDR0000066490, BC-BT-10, NCT00003458
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: SNUCH-SCT-1102, NCT01342237
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 6 to 18 Sponsor: Other Protocol IDs: HSJD-GLIOMAS-IC, NCT01574092
|
|
7.
|
Phase: Phase I Type: Treatment Status: Active Age: 3 to 22 Sponsor: Pharmaceutical / Industry Protocol IDs: 07-098, NCT00634231
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 3 at diagnosis Sponsor: Other Protocol IDs: SJYC07, SJCRH-SJYC07, NCT00602667
|
|
9.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 2 to 25 Sponsor: Other Protocol IDs: 2005P001629, NCT01115777
|
|
10.
|
Phase: No phase specified Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: 2011OC057, MT2011-09C, NCT01505569
|